Publication rates in small German trials remained low five years after trial completion

• Published in: Contemporary clinical trials Vol. 121; p. 106899
• Main Authors: Jansen, M S, Dekkers, O M, Groenwold, R H H, Siegerink, B
• Format: Journal Article
• Language: English
• Published: United States 01-10-2022
• Subjects: Germany; Humans; Publishing; Germany; Publication rates; Primary outcomes; Sample size; Small trials; Time-to-publication
• ISSN: 1551-7144; 1559-2030
• DOI: 10.1016/j.cct.2022.106899

To investigate publication rates in small trials and to explore which factors are associated with publication rates in small trials, including sample size, the type and number of primary and secondary outcomes.
We studied a subgroup of 'small' trials from a pre-existing dataset (IntoValue), containing German trials completed between 2009 and 2017. Small trials were defined as phase II-III, III and IV trials with 150 or fewer participants. We performed an updated publication search and collected additional data from online trial records.
Out of 499 trials, 325 (65%) trials published their results in a journal article or dissertation. Median time-to-publication was 3.41 years (95% CI: 3.04-4.10). Planned sample size was not associated with publication rates, but the difference between planned and achieved sample size was (per 10% unsuccessfully recruited participants, HR = 0.95, 95% CI: 0.91-1.00). Phase III vs. II-III trials, studied intervention (device vs. other) and clearly vs. unclearly defined primary outcomes predicted a higher likelihood of earlier publication.
About 35% of small trials in Germany remain unpublished, even after an extensive follow-up period of over 9 years. Publication rates are low and were associated with sample size, trial phase and type of intervention.